ArticleNeuroradiology2021

Dynamic contrast-enhanced MRI may be helpful to predict response and prognosis after bevacizumab treatment in patients with recurrent high-grade glioma: comparison with diffusion tensor and dynamic susceptibility contrast imaging.

Yae Won Park et al.PubMed ↗Publisher ↗

No numbers read from the abstract.